Biopharma Watch: RegeneRx Adds $666K To Offering
June 7, 2010 (FinancialWire) — RegeneRx Biopharmaceuticals, Inc. (AMEX: RGN), a biopharmaceutical company said that the underwriters of its recently completed public offering of units have exercised an option to purchase an additional 1,624,750 units at $ …